| __timestamp | Regeneron Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2819557000 | 9757000 |
| Thursday, January 1, 2015 | 4103728000 | 1253000 |
| Friday, January 1, 2016 | 4860427000 | 5421000 |
| Sunday, January 1, 2017 | 5872227000 | 154584000 |
| Monday, January 1, 2018 | 6710800000 | 301034000 |
| Tuesday, January 1, 2019 | 7863400000 | 380833000 |
| Wednesday, January 1, 2020 | 8497100000 | 540099000 |
| Friday, January 1, 2021 | 16071700000 | 701887000 |
| Saturday, January 1, 2022 | 12172900000 | 933013000 |
| Sunday, January 1, 2023 | 13117200000 | 1243336000 |
| Monday, January 1, 2024 | 14202000000 |
Data in motion
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Regeneron Pharmaceuticals, Inc. and Sarepta Therapeutics, Inc. have showcased contrasting revenue trajectories. Regeneron, a leader in the biotech industry, has seen its revenue soar by over 360% from 2014 to 2023, peaking at approximately $13.1 billion in 2023. This growth reflects its robust pipeline and successful product launches.
Conversely, Sarepta Therapeutics, known for its focus on genetic medicine, has experienced a more modest revenue increase, growing nearly 127 times from 2014 to 2023, reaching around $1.24 billion. This growth, while impressive, highlights the challenges and opportunities in the niche market of genetic therapies. As these companies continue to innovate, their revenue trends offer a glimpse into the evolving landscape of the biotech sector.
Novo Nordisk A/S vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Johnson & Johnson or Regeneron Pharmaceuticals, Inc.?
Revenue Insights: Johnson & Johnson and Sarepta Therapeutics, Inc. Performance Compared
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs Sarepta Therapeutics, Inc.
Revenue Showdown: Catalent, Inc. vs Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Sarepta Therapeutics, Inc. or PTC Therapeutics, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Arrowhead Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Geron Corporation: Who Leads in Yearly Revenue?
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Celldex Therapeutics, Inc.